13F Holdings
中文EN

Remedium Capital Partners, LLC

WEST PALM BEACH FL · SEC CIK 0002104501

2026Q22026Q1 9 earlier quarters 🔒
$451.63M2026Q2 reported value
6Positions
100.0%Top 10 weight · largest 33.0%
1 / 1New / sold out
Reported value over time$451.63M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

ORKA 33.0%
SYRE 28.8%
Apogee Therape 17.2%
DMRA 11.8%
JBIO 7.8%
CBIO 1.4%

2026Q2 top buys estimated at quarter-end value

CBIO New+$6.50M
SYRE Added+$704,736
Apogee Therapeut Added+$411,463

2026Q2 top sells estimated at quarter-end value

Crescent Biophar Sold out-$6.64M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
ORKA Oruka Therapeutics Inc $149.00M32.99%1,565,661 00.0% — Unchanged
SYRE Spyre Therapeutics Inc $129.99M28.78%1,464,169 7,9380.5% $704,736 Added
— Apogee Therapeutics Inc $77.87M17.24%586,691 3,1000.5% $411,463 Added
DMRA Damora Therapeutics Inc $53.20M11.78%2,045,473 00.0% — Unchanged
JBIO Jade Biosciences Inc $35.06M7.76%1,577,750 00.0% — Unchanged
CBIO Crescent Biopharma Inc $6.50M1.44%361,250 361,250— $6.50M New
— Crescent Biopharma Inc $00.00%0 -361,250-100.0% -$6.64M Sold out